a BavaRiAn eValuatiOn of Dorsal Root Ganglion (DRG) Stimulation for the Treatment for Chronic Post Surgical Pain of the Groin (BRAVO)
BRAVO: a BavaRiAn eValuatiOn of DRG Stimulation for the Treatment for Chronic Post Surgical Pain of the Groin
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
München, Germany
- Algesiologikum Zentrum für Schmerzmedizin
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- The patient is at least 18 years old
- The patient is willing and able to comply with the examination schedule and the trial schedule.
- The patient has suffered from chronic post-surgical neuropathic groin pain for at least 6 months
- Conservative treatments of the chronic pain including medication, physiotherapy and interventions have been exhausted
- The pain level at the time of the baseline examination is at least 60mm on the visual analogue scale (VAS) in the primary pain area (groin pain)
- The patient is able to give consent in writing
Exclusion Criteria:
- Pregnant or breastfeeding patients or those who plan to become pregnant during the study
- It has been established in an examination by the tester that the pain has significantly worsened or changed its characteristics in the course of the previous month.
- In the last 30 days, the patient has been treated with corticosteroids on an area scheduled for the stimulation.
- In the last 3 months, the patient has been treated with radio frequency therapy on an area scheduled for the stimulation.
- The patient has already been treated with an active implantable device, including an implantable cardioverter defibrillator, pacemaker, spinal cord stimulator or an intrathecal medication pump.
- The patient is not able to operate the stimulation device
- The patient is currently suffering from an infection
- The patient has participated in another clinical study in the last 30 days
- The patient has a coagulation disorder or is taking anti-coagulants, which would make participation impossible, as per the study doctor
- The patient has been diagnosed with a malignancy in the past 2 years
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Treated subjects
All subjects recruited and treated with the Axium neurostimulator
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Pain Relief - Assessed by Change in Pain Intensity Assessed using a Visual Analogue Scale (VAS) from Pre-Treatment Baseline
Time Frame: Post treatment at; 1 week and 1, 3, 6 and12 months
|
Post treatment at; 1 week and 1, 3, 6 and12 months
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Estimate)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 15-SMI-2013
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.